Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.

Journal of gastroenterology - 1 Aug 2014

Aizawa Nobuhiro, Enomoto Hirayuki, Takashima Tomoyuki, Sakai Yoshiyuki, Iwata Kazunari, Ikeda Naoto, Tanaka Hironori, Iwata Yoshinori, Saito Masaki, Imanishi Hiroyasu, Iijima Hiroko, Nishiguchi Shuhei

Abstract excerpt

BACKGROUND: This study aimed to examine the therapeutic effect and prognostic indicators of pegylated interferon (PEG-IFN) and ribavirin (RBV) combination therapy in thrombocytopenic patients with chronic hepatitis C, hepatitis C virus (HCV)-related cirrhosis, and those who underwent splenectomy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interferon alpha-2
Share to Interferons
Share to Interleukins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polyethylene Glycols

Share to Ribavirin

Share to Spleen

Share to Splenectomy

Share to Thrombocytopenia

Source

Open in PubMed Open full text

Identifiers

PMID: 24065124
DOI: 10.1007/s00535-013-0884-0
PMCID: PMC4124258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24065124-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.PMID 24065124Read ↗

Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C.Semantic proximity Read ↗

Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.Semantic proximity Read ↗

A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia.Semantic proximity Read ↗

Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose.Semantic proximity Read ↗

Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism.Semantic proximity Read ↗

Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis.Semantic proximity Read ↗

Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C.Semantic proximity Read ↗

[Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection].Semantic proximity Read ↗

Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents.Semantic proximity Read ↗

Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C.Semantic proximity Read ↗

Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores: How Much Do Routine Blood Tests Tell About Liver Fibrosis in Chronic Hepatitis C?Semantic proximity Read ↗

Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.